LT40-41

18 important questions on LT40-41

What did Mary Laskers philantrophy?

The war on cancer, budget national cnacer instiutie

What did Sydney Farber?

Late 1940s, all experiments with toxic drugs, pathologists, leukemia doctor researcher, fund raiser

What did Dr. Pinkel?

St. Jude's Hospital (memphis)
- more toxic chemicals
- radiotherapy brain and chemotherapy spinal fluid
- no success --> doubing dose
- cure rate (> 5 year survival) from 0,07% in 1962 to >50% in 1971 (later >70%)   

Chance discovery of almost all drugs
Scant knowledge of how anti-leukemic drugs work in human
Sceptical that medical treatment alone could expalin the cure of ALL
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

Tell something about Nixon's War on cancer

First therapeutic optism: cure of rare cancers <1% like ALL
National cancer act 1971
Aim: cure more prevalent solid tumors (breast, lung, intestinal cancer)

Why was there a problem in curing solid tumors?

Cause/development closely related to ageing process
Solid tumors less sensitive to anti-cancer drugs than leukemia

What were discussion points in the cancer treatment development?

Medical thinking: agressive treatment <-> systemic disease
Realistic image: winding road of progress
Cure individual vs prevention population (endogenous vs exogenous): money politics
Ethical dilemmas, patient = research subject, doctor = researcher

What was the influence of non-medical factors in cancer treatment?

significant national differences in practice, but not in results
Many uncertainties -> many phiscians chose the most agressive, interventionist treatment (better safe than sorry_
Decline radical mastectomy 1970s: feminist and  patient movement.

Wat is het verschil tussen complement dependent cytotxiicty and antibody dependent cytotoxicity van rituximab?

Binding anti-CD20 to B cell induces activation of complement cascade. Binding van anti-CD20 zorgt ervoor dat daarna een complement receptor er aan gebonden kan worden. Destrution by NK lymphocytes.

Binding anti-CD20 to B cell, Fc receptoren zorgt voor release of cytotxic molecules, called perforins.
Fc/CR-mediated opsonic phagocytosis door macrophagen

What is brentuximab vedotin?

Directed against CD30
Antibody drug conjugate (ADC)

Cojugated to monomethyl auristatin E (MMAE), potent antitubin agent protease-cleavable linker 

ADC binds to CD30
ADC-CD30 complex traffics to lysosome
MMAE is released
MMAE disrupts microtubule network
G2/M cell cycle arrest
Apoptosis

What are side effects of the monoclonal antibodies, bites and CAR-T cells?

Frequently severe side effects due to cytokine release syndrome.
Allergic reactions at beginning of infusion (MoAbs)

Cytokine release syndrome: hypotension, fever, tachycardia, dyspnea.

Tumor lysis syndrome
- uric acid >> renal failure due to formation of uric acid crystals     
- release LDH

MMAe: conjugated to anti-CD30: polyneuropathy

What cytokines are involved in monoclonal antibodies, bites, CAR-T cells, what are the side effects?

Cytokine release syndrome: hypotension, fever, tachycardia, dyspnea

Cytokines:
- TNF-alfa
- IFN gamma
- IL6
- IL2

What side effects does MMAE give?

Monomethyl auristatin E
conjugated to anti-CD30

Polyneuropathy: damage of the sensory nerves in hands and feet

In what cancers can you use tyrosine kinase inhibitors?

CLL plus other B cell lymphomas
CLL has constituitive activation of B cell receptor. You get down stream signaling and molecule was developed and was particular aiming ata the BTK molecule.
If you inhibit TK, you stop the constituitive signaling cascade.

Eg inhibitor of BR3 kinase, idelalisib, oral durgs., ibrutinb
You can take those drugs every day until resistance develops or until you get side effects and cannot tolerate the drugs any more.

Welke twee medicijnen zijn tyrosine kinase inhibitors?

Ibrutinib
idelalisib

What is a BRAF V600E inhibitor?

Used in hairy cell leukmia (indolet B cell lymphoma), multiple myeloma

A molecule of the signalling cascade is attacked, which results in kill of the tumor cells

What is a FLT3 inhibitor?

FLT3 is a growth factor receptor.
You give an inhibitor to attack the growth factor receptor which is constituively active, and keeps on inducing signaling to the nucleus with increased proliferationd and decreased apoptosis.

After inhibition of this mutated molecule, you get decreased proliferation and increased apoptosis.

If you add midostaurin, you get an significant increase in the probability of survival.

What happens when PD-1L binds to PD-1?

Inhibiting of T cell resposne

What is the therapy for AML?

Cytarabin daunorubicin, dosis escalation
Non-classical chemotherapy
- gemtuzumab - ozagomycin
- FLT3 inhibitors PKC, other new drugs
- Allogeneic stem cell transplantation

The question on the page originate from the summary of the following study material:

  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
Remember faster, study better. Scientifically proven.
Trustpilot Logo